The N-cadherin surface expression in chemo-resistant bladder cancer might play a role in tumor progression and the decrease in surface N-cadherin through SFN; this might be one mechanism contributing to the reduced migration capacity of (at least) the drug-resistant T24 cells. The gene discussed is CDH2; the disease is urinary bladder carcinoma.